Skip to Content

Rule

New Animal Drugs; Change of Sponsors' Addresses

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Final rule.

SUMMARY:

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect changes of address for Alpharma Inc.; Intervet Inc.; and Vètoquinol N.-A., Inc.

DATES:

This rule is effective October 13, 2004.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

David R. Newkirk, Center for Veterinary Medicine (HFV-100), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301-827-6967; e-mail: david.newkirk@fda.gov.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

Alpharma Inc., One Executive Dr., P.O. Box 1399, Fort Lee, NJ 07024, has informed FDA of a change of address to One Executive Dr., Fort Lee, NJ 07024. Intervet, Inc., P.O. Box 318, 405 State St., Millsboro, DE 19966, has informed FDA of a change of address to 29160 Intervet Lane, P.O. Box 318, Millsboro, DE 19966. Vètoquinol N.-A., Inc., 2000 chemin Georges, Lavaltrie (PQ), Canada J0K 1H0, has informed FDA of a change of address to 2000 chemin Georges, Lavaltrie (PQ), Canada J5T 3S5. Accordingly, the agency is amending the regulations in 21 CFR 510.600 to reflect these changes of sponsors' addresses.

This rule does not meet the definition of “rule” in 5 U.S.C. 804(3)(A), because it is a rule of “particular applicability.” Therefore, it is not subject to congressional review requirements in 5 U.S.C. 801-808.

Start List of Subjects

List of Subjects in 21 CFR Part 510

End List of Subjects Start Amendment Part

Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine,

End Amendment Part Start Part

PART 510—NEW ANIMAL DRUGSEnd Part Start Amendment Part

1. The authority citation for

End Amendment Part Start Authority

Authority: 21 U.S.C. 321, 331, 351, 352, 353, 360b, 371, 379e.

End Authority
[Amended]
Start Amendment Part

2. Section 510.600 is amended:

End Amendment Part

a. In the table in paragraph (c)(1) in the entry for “Alpharma Inc.”, by removing “P.O. Box 1399,”;

b. In the table in paragraph (c)(1) in the entry for “Intervet, Inc.”, by removing “Intervet, Inc., P.O. Box 318, 405 State St.” and by adding in its place “Intervet Inc., P.O. Box 318, 29160 Intervet Lane”;

c. In the table in paragraph (c)(1) in the entry for “Vètoquinol N.-A., Inc.”, by removing “J0K 1H0” and by adding in its place “J5T 3S5”;

d. In the table in paragraph (c)(2) in the entry for “046573”, by removing “P.O. Box 1399”;

e. In the table in paragraph (c)(2) in the entry for “057926” by removing “Intervet, Inc., P.O. Box 318, 405 State St.” and by adding in its place “Intervet Inc., P.O. Box 318, 29160 Intervet Lane”; and

f. In the table in paragraph (c)(2) in the entry for “059320”, by removing “J0K 1H0” and by adding in its place “J5T 3S5”.

Start Signature

Dated: September 16, 2004.

Bernadette A. Dunham,

Deputy Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine.

End Signature End Supplemental Information

[FR Doc. 04-22915 Filed 10-12-04; 8:45 am]

BILLING CODE 4160-01-S